jump to content jump to footer

Customizable reading templates for therapy response assessment

mint Lesion offers customizable reading templates for therapy response assessment in clinical care and research. Adapt parameters, define lesion categories, and evaluate responses. Track key measurements like diameter, volume, SUV, and ADC, ensuring compliance with required minimum sizes. Automate sum calculations for response determination and integrate clinical data such as ctDNA or PSA values. Document multiple lesions, compare absolute and relative changes over time, and visualize trends with interactive charts. Generate comprehensive reports with tables and graphs for a clear longitudinal overview.

Key features:

  • Easily customizable parameters
    • Questions for manual response evaluation
    • Lesion categories (e.g., target lesions, non-target lesions)
    • System-derived lesion states (e.g., normalized for lymph nodes)
    • Key measurement values (e.g., longest diameter, short axis, volume, SUV, ADC, etc.), including required minimum size for each lesion category
    • Sum of measurements for response determination (e.g., sum of diameter or sum of volume)
    • Clinical data (e.g., ctDNA or PSA values)
  • Ability to document the count of multiple (non-target and new) lesions
  • Automatic calculations of absolute and relative differences to baseline, previous timepoint and nadir
  • Interactive charts displaying all relevant values over time, including clinical data, with dynamic filtering options
  • Comprehensive reports including tables and graphs for a fast and clear longitudinal overview
Woman watching the Mint Medical and contextflow webinars on lung cancer screening in Germany on Youtube
Webinar series to explore different aspects of lung cancer screening in Germany
Webinar Series: Lung Cancer Screening in Germany - From Evidence to Implementation
Lung cancer remains one of the leading causes of cancer-related mortality worldwide. In Germany, the introduction of a national lung cancer screening…
Read more
From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials
The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…
Read more
Mint Medical and mediaire strengthen the prostate cancer care pathway with AI-Powered MRI Solutions
Mint Medical, a Snke company, and mediaire announce a collaboration to advance AI‑powered MRI workflows through the interoperability of mint Lesion…
Read more
scroll-top